Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Terblanche

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 15, 1986
[Prognostic parameters in patients with advanced non-Hodgkin's lymphoma]A P Terblanche, G Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 6, 1992
Oesophageal cancer in three regions of South AfricaA P Terblanche, E U Schmidt
European Journal of Cancer & Clinical Oncology|December 1, 1988
The prognostic significance of age in patients with advanced Hodgkin's diseaseA P Terblanche, G Falkson, L Matzner
Journal of Exposure Analysis and Environmental Epidemiology|July 1, 1991
Self-reported exertion levels on time/activity diaries: application to exposure assessmentM Schwab, A P Terblanche, J D Spengler
Cancer Treatment Reports|October 1, 1984
Phase II trial of mitoxantrone in patients with primary liver cancerG Falkson, B J Coetzer, A P Terblanche
Journal of Exposure Analysis and Environmental Epidemiology|January 1, 1993
Exposure to air pollution from transitional household fuels in a South African populationA P Terblanche, C M Nel, L Opperman, et al.
Journal of the Air & Waste Management Association|July 1, 1991
Relationship between self-reported activity levels and actual heart rates in teenagersA P Terblanche, H Ozkaynak, J D Spengler, et al.
Oncology|January 1, 1988
Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphomaD A Vorobiof, A P Terblanche, C I Falkson, et al.
Investigational New Drugs|December 1, 1987
Mitoxantrone in the treatment of acute leukemiaD A Vorobiof, G Falkson, M A Coccia-Portugal, et al.
Investigational New Drugs|December 1, 1988
Trimetrexate in advanced carcinoma of the esophagusA S Alberts, G Falkson, M Badata, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 15, 1986
[Prognostic parameters in patients with advanced non-Hodgkin's lymphoma]A P Terblanche, G Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 6, 1992
Oesophageal cancer in three regions of South AfricaA P Terblanche, E U Schmidt
European Journal of Cancer & Clinical Oncology|December 1, 1988
The prognostic significance of age in patients with advanced Hodgkin's diseaseA P Terblanche, G Falkson, L Matzner
Journal of Exposure Analysis and Environmental Epidemiology|July 1, 1991
Self-reported exertion levels on time/activity diaries: application to exposure assessmentM Schwab, A P Terblanche, J D Spengler
Cancer Treatment Reports|October 1, 1984
Phase II trial of mitoxantrone in patients with primary liver cancerG Falkson, B J Coetzer, A P Terblanche
Journal of Exposure Analysis and Environmental Epidemiology|January 1, 1993
Exposure to air pollution from transitional household fuels in a South African populationA P Terblanche, C M Nel, L Opperman, et al.
Journal of the Air & Waste Management Association|July 1, 1991
Relationship between self-reported activity levels and actual heart rates in teenagersA P Terblanche, H Ozkaynak, J D Spengler, et al.
Oncology|January 1, 1988
Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphomaD A Vorobiof, A P Terblanche, C I Falkson, et al.
Investigational New Drugs|December 1, 1987
Mitoxantrone in the treatment of acute leukemiaD A Vorobiof, G Falkson, M A Coccia-Portugal, et al.
Investigational New Drugs|December 1, 1988
Trimetrexate in advanced carcinoma of the esophagusA S Alberts, G Falkson, M Badata, et al.
Pageof 2